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Background: Coronavirus disease 2019 (COVID-19) has affected a huge number of people 
around the world. It has increased worldwide mortality and morbidity and is accompanied by 
different signs and symptoms. Some researchers have linked oral manifestations as introductory 
signs for COVID-19, such as vesiculobullous lesions, non-specific stomatitis, and oral ulcers. The 
oral cavity has been perceived as a potential reservoir for asymptomatic COVID-19 infection, 
specifically the salivary glands and the oral mucosa. This study builds on a previous case report 
by the authors on COVID-19 associated gingival bleeding in an attempt to investigate the 
generalization of this relation. Methods: A cross-sectional survey based on a structured, pre-
tested, and validated questionnaire that was adapted and modified by the authors was carried 
out electronically for a minimal sample size of patients that was calculated for this study 
beforehand. This study was approved by the Batterjee Medical College ethical committee and 
data collection followed a structured criteria and a clear work plan based on the established 
inclusion criteria.  Results: The questionnaire had a high response rate of 315 participants. 
63.2% (n=199) reported gum bleeding during virus infection time – 25.6% (n=51) of whom 
reported that this symptom was present prior to COVID-19 infection. 88.9% (n=177) of 
participants reported only mild bleeding. Gingival bleeding was more prevalent among females 
63.8% (n=127) compared to males 36.2% (n=72) (odds ratio: 0.859 [95% CI, 0.530 to 1.394]). 
Conclusion: Gingival bleeding may be considered as one of the signs of COVID-19 and is a 
prevalent symptom as reported by infected patients. However, a larger sample size and 
investigation of hospitalized moderate and severe cases of the disease would help elucidate the 
actual association. 
Keywords: COVID-19; gingival bleeding; dental; infectious diseases; periodontal disease
Introduction 
The first instance of infection with the severe 
acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) was reported in the city of 
Wuhan, China in December 2019 resulting 
in the novel coronavirus disease 2019 
(COVID-19).1 The World Health 
Organization (WHO) announced COVID-19 
a public health emergency of international 
concern in January 2020. Ever since, the 
COVID-19 pandemic has infected a large 
number of individuals worldwide. The 
disease has clearly increased mortality and 
morbidity around the world, and it has a 
variety of symptoms and impacts. Some of 
the symptoms associated with COVID-19 
include fever, dry cough, headaches, 
weakness, and others.2,3 Moreover, age, 
gender, ethnicity, and comorbidities are risk 
factors that increase the risk of SARS-CoV-2 
infection complications and mortality.4 
It has been reported that some 
COVID-19 patients, despite being negative 
for the viral nucleic acid, often still present 
with a high level of inflammation, indicating 
that inflammation is a major feature in 
COVID-19 patients. Furthermore, excessive 
inflammation, a depressed immune system, 
and an active cytokine storm substantially 
contribute to the pathogenesis of COVID-
19.5 In the early stages of coronavirus 
infection, dendritic cells and epithelial cells 
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are activated and express a cluster of 
proinflammatory cytokines and chemokines 
including interleukin (IL)-1β, IL-2, IL-6, IL-
8, both interferon (IFN)-α/β, and tumor 
necrosis factor (TNF) contributing to the 
development of disease.6,7 
The oral cavity has been perceived as 
a potential reservoir for asymptomatic 
COVID-19 infection, specifically the salivary 
glands and the oral mucosa, owing to the 
high expression of angiotensin-converting 
enzyme 2 (ACE2) receptors in minor salivary 
glands, which is also the functional receptor 
of SARS-CoV.8 In fact, the expression of 
ACE2 receptors in minor salivary glands is 
higher than that in the lungs. SARS-CoV 
RNA can be detected in saliva before lung 
lesions appear, explaining the presence of 
asymptomatic infections. The salivary gland 
could be a major source of SARS-CoV in 
saliva. The positivity rate of COVID-19 in 
patients’ saliva can reach 91.7%, attributing 
to the potential infectivity of saliva.8 
  Some researchers have linked oral 
manifestations to COVID-19 infections, such 
as vesiculobullous lesions, non-specific 
stomatitis, and oral ulcers.9,10 Oral 
manifestations have also been associated 
with COVID-19 as an initial symptom in 
several studies. Carreras-Presas et al. for 
example, described vesiculobullous lesions 
in the oral cavities of SARS-CoV-2 infected 
patients.11 
This study builds on a previous case 
report by the authors on COVID-19 
associated gingival bleeding, where there 
were anecdotal reports of unprecedented 
profuse gingival bleeding that was not 
present before active signs of COVID-19 
developed, specifically preceding or 
alongside fever.12 Doubts about the 
relationship between COVID-19 and dental 
health exist however, as patients can be 
affected by oral manifestations either as a 
typical pattern resulting from the direct 
infection, or these lesions can result from the 
systemic deterioration caused by the 
infection, or as adverse reactions from 
treatment.13  
It has recently been established that 
periodontitis was associated with a higher 
risk of ICU admission, assisted ventilation, 
COVID-19 death, and elevated blood levels 
of biomarkers linked to worse disease 
outcomes.14 Asymptomatic COVID-19 
patients may present for emergency dental 
treatment and are expected to have saliva – 
a confirmed source of infection – 
contaminated with the virus. Moreover, the 
conjunctival mucosa and upper respiratory 
tract are connected by the nasolacrimal duct 
and share ACE2 on their cell membrane.15 
This exposes dental healthcare personnel to 
the risk of infection via direct exposure of the 
conjunctiva to droplets from patients during 
dental treatment.16 
The presence of initial or inaugural 
signs for COVID-19 in the oral cavity may 
bring to the attention of dental practitioners 
the suspicion of current or imminent 
infection in otherwise asymptomatic carriers 
or patients. Hence, the aim of this 
questionnaire-based study was to further 
investigate direct or indirect associations of 
introductory or concurrent gingival bleeding 
with COVID-19. 
Materials and Methods 
This study was approved by the Batterjee 
Medical College ethical committee (UB-
RES-2020-0049) and data collection 
followed a structured criteria and a clear 
work plan based on the established inclusion 
criteria. 
A cross-sectional survey based on a 
structured, pre-tested and validated 
questionnaire that was adapted by the 
authors, and was modified from previous 
studies to suit the local population was 
carried out electronically to assess gingival 
bleeding association with COVID-19 in 
positive patients. The purpose of the study 
was explained in the covering letter of the 
questionnaire, which contained eight 
questions. Participating subjects and 
patients signed an informed consent. 
The sample size was calculated based 
on the results of Chen et al., who reported a 
prevalence of sore throat in 17.4% of COVID‐
19 patients.17 Based on the results of Chen et 
al.’s study, the present study’s sample 
consisted of 220 patients each with a 
confirmed diagnosis of COVID‐19. 
Considering a possible loss of about 10% of 
patients, a total of 242 patients formed the 
final sample size to be recorded for the study 
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according to the following equation: sample 
size = Z1‑a/2 2 p (1-p) /d2. Z1‑a/2 = 1.96, 
where p = expected proportion in the 
population based on previous studies or 
pilot studies (17.4%), and d = 0.05. 
The subjects were selected using a 
convenient sampling method. Participants 
were eligible to be included if they: 1) were 
above 18 years old, 2) understood the Arabic 
or English language, and 3) currently are or 
were COVID-19 positive patients within the 
past six months, to allow for patients to 
recall the symptoms. Those who did not 
meet any of those criteria were excluded 
from the study. A positive COVID-19 
infection was confirmed via the real-time 
reverse transcription polymerase chain 
reaction (rRT-PCR) test for the qualitative 
detection of nucleic acid from SARS-CoV-2 
in upper respiratory specimens from 
nasopharyngeal or oropharyngeal swabs. 
Statistical analyses were carried out 
using the SPSS software package (version 
20.0). Descriptive measures presented 
included percentages and corresponding 
95% confidence intervals (CIs). P < 0.05 was 
considered statistically significant. The 
association between gingival bleeding and 
COVID-19 infection was analyzed using 
logistic regression and data were reported as 
odds ratios (ORs) with 95% CI. 
Results 
The response rate for the questionnaire was 
higher than the calculated minimum sample 
size, as 315 participants responded to the 
survey. The demographic data of the studied 
patients is depicted in Table 1. The majority 
of the studied patients were females (65.1%; 
n=205), and approximately half of the 
patients were young adults ranging between 
18-30 years of age (49.5%; n=156), with a 
gradual decrease in number in each age 
category up to the age of 60 years or more. 
The mean age of the studied patients was 
33.4 ± 10.7 years. Furthermore, the 
breakdown of oral hygiene practices during 
the phase of infection revealed that nearly 
half of the patients (47.3%; n=149), 
practiced in accordance to the universal 
guidelines on proper tooth brushing of twice 
daily. The practice of flossing was reported 
among only 33% (n=104) of participants, 
while the remainder declined its use. 
Table 1. Description of the studied patients 
according to demographic data 
SD: standard deviation 
The descriptive statistics of the 
studied patients illustrating gum bleeding 
during the period of virus infection are 
presented in Table 2. It shows that nearly 
two-thirds of the studied patients (63.2%; 
n=199) reported that gum bleeding occurred 
during the period of virus infection, among 
them, 74.4% (n=148) reported that this 
symptom was not present prior to 
contracting SARS-CoV-2 and was not a 
complaint of theirs prior to infection. A large 
percentage of the patients (53.3%; n=106) 
reported that bleeding occurred 
spontaneously without provocation and 
among those who reported bleeding, 89.4%, 
(n=178) stated that it stopped shortly after 
and did not continue on its own. The 
majority of patients (78.4%; n=156) reported 
that there was no specific time that bleeding 
occurred during the day, and most (88.9%; 
n=177) described the degree of bleeding as 
being mild. Finally, 47.7% of patients (n=95) 
stated that bleeding discontinued post-
COVID-19.
  (n = 315) 
No. % 
Q1. Sex   
Male 110 34.9 
Female 205 65.1 
Q2. Age   
18 – 30 156 49.5 
31 – 40 89 28.3 
41 – 50 46 14.6 
51 – 60 18 5.7 
60+ 6 1.9 
Mean ± SD 33.4 ±10.7 
Median (Min-Max.) 31 (18-65) 
Q3. How many times do you 
brush your teeth daily? 
  
Once a day 109 34.6 
Twice a day 149 47.3 
Thrice a day 41 13 
Less than 3 times weekly 12 3.8 
I rarely brush my teeth. 4 1.3 
Q4. Do you use dental floss?   
No 211 67 
Yes 104 33 
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Table 2. Description of the studied patients 
according to gingival bleeding during time of 
virus infection 
 No. % 
Q5. Did you have gum 
bleeding during time of 
virus infection? 
(n = 315) 
No 116 36.8 
Yes 199 63.2 
Q6. If you answered yes, did 
you suffer from bleeding 
gums before getting 
infected with COVID-19? 
(n = 199) 
No 148 74.4 
Yes 51 25.6 
Q7. Is bleeding related to 
the presence of provocation 
factors? (for example: hot 
food, hard food, tooth 
brushing, etc.) 
(n = 199) 
No 106 53.3 
Yes 93 46.7 
Q8. Does bleeding continue 
on its own? 
(n = 199) 
No 178 89.4 
Yes 21 10.6 
Q9.What is the time of day 
that you usually suffer from 
bleeding gums the most? 
(n = 199) 
After waking up 23 11.6 
In the morning 9 4.5 
In the evening 6 3.0 
Before sleeping 5 2.5 
Not related to specific time 156 78.4 
Q10.What is your 
assessment of the amount 
of bleeding?  
(n = 199) 
Mild 177 88.9 
Moderate 15 7.5 
Severe 4 2.0 
Very severe 3 1.5 
Q11. Did this bleeding 
disappear after recovery? 
(n = 199) 
No 104 52.3 
Yes 95 47.7 
 
Finally, the demographic data 
describing the relation between gingival 
bleeding and SARS-CoV-2 infection is 
presented in Table 3. It was noticed that 
gingival bleeding was more prevalent among 
females (63.8%; n=127) compared to males 
(36.2%; n=72) (odds ratio, 0.859 [95% CI, 
0.530 - 1.394]). A statistically significant 
association was found among the age group 
of 31-40 years (28.6%; n=57) (odds ratio, 
8.929 [95% CI, 1.018 – 78.341]). Moreover, 
it was observed that gingival bleeding was 
more prevalent among patients who brushed 
twice a day during the phase of infection 
(47.2%; n=94) (odds ratio, 0.952 [95% CI, 
0.570 – 1.592]), and less frequent among 
flossers (32.7%; n=65) (odds ratio, 1.044 
[95% CI, 0.642 – 1.698]). 
Discussion 
SARS-CoV-2, a novel coronavirus, was 
initially discovered in late 2019 and has 
quickly grown to create a global pandemic.18 
COVID-19 was first described in Wuhan, 
China and was designated a public health 
emergency in January 2020.1,3 It is 
characterized by a variety of clinical 
manifestations; in a typical case, a high fever 
appears following dry cough and in some 
cases, viral pneumonia develops and 
advances, resulting in shortness of breath.19 
COVID-19 is notable for its capacity to 
generate an overactive immunological 
response in the host, known as a cytokine 
storm, which results in significant tissue 
destruction, notably in the connective tissue 
of the lungs.20 
Several studies have pointed to the 
oral cavity as the primary source of SARS-
CoV-2 infection. SARS-CoV-2 expression 
has been found in the oral epithelium, 
phlegm, and swabs of human saliva.21,22,23 It 
is known that the oral cavity may exhibit 
manifestations of underlying diseases such 
as oral ulcerations, gingival bleeding, 
glossitis, oral pain, or halitosis.24,25 Oral 
tissue ulceration or blistering are the most 
common symptoms of viral infections.26 
Recurrent mouth ulcers may be an early sign 
of COVID-19. According to a case report, an 
irregular ulcer on the dorsal side of the 
tongue of a 45-year-old female patient 
started as a painful inflammation of a tongue 
papilla and turned into an erythematous 
macula after 24 hours, which evolved into an 
irregular and asymptomatic ulcer preceding 
testing positive for COVID-19.10 Dry mouth 
and amblygeustia are two other 
predominant oral-related symptoms that 
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were experienced by a very high proportion 
of COVID-19 patients, implying that oral 
symptoms can be considered as initial 
symptoms of COVID-19 infection.27 The first 
description of oral mucosal manifestations 
of COVID-19 was reported by Cebeci 
Kahraman and Çaşkurlu in 2020 and they 
stated that the mucosal lesions were not just 
small enanthema, but were composed of 
diffuse oropharyngeal erythema, petechia, 
and pustule formation suggesting that oral 
mucosal involvement should be kept in mind 
as a potential symptom of COVID-19.28
 
Table 3. Relation between gingival bleeding during time of virus infection and demographic 
data 
Demographic Data Did you have gum bleeding 
during time of virus 
infection? 




(n = 116) 
Yes  
(n = 119) 
No. % No. % 
Sex         
Male 38 32.8 72 36.2 0.378 0.539 – – 
Female 78 67.2 127 63.8 0.859 (0.530 – 
1.394) 
Age         
18 - 30 56 48.3 100 50.3 5.760 0.218 – – 
31 - 40 32 27.6 57 28.6 8.929* (1.018 – 
78.341) 
41 - 50 17 14.7 29 14.6 8.906 (0.997 – 
79.599) 
51 - 60 6 5.2 12 6 8.529 (0.918 – 
79.239) 
60+ 5 4.3 1 0.5 10.000 (0.944 – 
105.921) 
Q3. How many times 
do you brush your 
teeth daily? 
        
Once a day 39 33.6 70 35.2 2.955 MCp= 
0.584 
– – 
Twice a day 55 47.4 94 47.2 0.952 (0.570 – 
1.592) 
Thrice a day 18 15.5 23 11.6 0.712 (0.343 – 
1.478) 
Less than 3 times 
weekly 
4 3.4 8 4 1.114 (0.315 – 
3.938) 
I rarely brush my 
teeth. 
0 0 4 2 - - 
Q4. Do you use dental 
floss? 
        
No 77 66.4 134 67.3 0.030 0.862 – – 
Yes 39 33.6 65 32.7 1.044 (0.642 – 
1.698) 
2: Chi-square test; MC: Monte Carlo; *: statistically significant at P ≤ 0.05; OR: odds ratio; CI: confidence 
interval; LL: lower limit; UL: upper limit
Furthermore, COVID-19 patients 
seem to be prone to coagulation dysfunction 
with signs of small blood vessel occlusion, as 
is evident by systemic, as well as cutaneous 
findings of ischemia in the limbs. These 
microcirculation disorders and cutaneous 
manifestations that patients with COVID-19 
may develop can clinically present as 
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findings that range from petechiae or tiny 
bruises, to nonpruritic blanching livedoid 
vascular eruptions on extremities, to plantar 
plaques, plantar vesicles, dry gangrene, or 
just bruising in the fingers and toes.29 Kalner 
and Vergilis also reported that the 
appearance of periorbital dyschromia may 
serve as an early cutaneous manifestation of 
COVID-19 and as a precursor for the 
systemic symptoms that seem to follow this 
presentation.30 
Besides viral invasion, it was 
speculated that oral symptoms may also be 
due to the patient's change in psychological 
status, poor oral hygiene, or microbiota 
imbalance caused by therapeutic drugs. 
High ACE2 expression in particular, can be 
found on the epithelial cells of the oral 
mucosa, which is enriched in epithelial cells 
of the tongue, thus providing possible routes 
of entry for SARS-CoV-2.21 Therefore, the 
oral mucosa might be at potential risk of 
infection by SARS-CoV-2, suggesting that 
oral symptoms could also be considered as 
initial symptoms of COVID-19, which might 
be new diagnostic criteria. At the same time, 
physicians should pay more attention to the 
oral condition and oral hygiene of patients 
and administer proper oral treatment or 
refer patients for dental care during the 
clinical treatment process.27 
Recently, oral health has been shown 
to have a significant impact on overall 
health, as several studies have suggested that 
cytokines or microbial products released 
systemically in response to oral infection 
promote inflammation in distant organs, 
increasing the risk of systemic disorders 
such as Alzheimer's disease, diabetes, 
atherosclerotic heart disease, and 
cerebrovascular disease. Furthermore, poor 
dental health has been linked to the 
development of complications in systemic 
disorders such as diabetes, chronic kidney 
disease, and liver disease according to 
research.31-36 
Recent research has suggested a link 
between periodontal disease and COVID-19. 
Its severity and progression may be 
influenced by the inflammatory response 
that occurs during periodontitis.37-39 
Furthermore, some investigations have 
suggested that this theory is the result of 
bacterial superinfection in the oral cavity. 
Periodontitis and COVID-19 problems may 
be linked by bacterial infections invading the 
gingival epithelium through ulceration.39-41 
Cytokine profiles in periodontal diseases 
have been studied and assessed and it has 
been indicated that in gingivitis, patients 
had noticeably higher IL-1ß and lower IL-8 
concentrations at later stages of the 
disease.42 COVID-19 and periodontitis have 
a high degree of similarity in the serum level 
change of key cytokine profiles, implying 
that there may be a link between the two 
diseases. Furthermore, because gene 
polymorphisms in cytokine-related genes 
such as IL-1α, IL-1ß, IL-6, IL-10, TNF-α, and 
INFγ affect periodontal disease, it is 
probable that they also affect COVID-19.43 
Other researchers have hypothesized that 
during SARS-CoV-2 infection, periodontal 
disease could be aggravated due to the down 
regulation of ACE2 and an increase in ACE 
and angiotensin II, thereby resulting in the 
involvement of several pro-inflammatory 
factors. Their studies have shown that due to 
the renin–angiotensin system in periodontal 
sites, ACE2 might play a fundamental role in 
the under- or overexpression of cytokines 
associated with periodontal disease, such as 
IL-6, IL-7, TNF-α, IL-2, IL-1β, monocyte 
chemoattractant protein (MCP)-1, and 
transforming growth factor (TGF)-β, mainly 
during coinfection with SARS-CoV-2, where 
ACE2 is underexpressed rendering patients 
unresponsive to inflammatory processes and 
facilitating periodontal loss. 44,45 
Asymptomatic COVID-19 patients 
may present for emergency dental 
treatment. These patients are expected to 
have saliva contaminated with the virus and 
they are a confirmed source of infection.46 
Moreover, the conjunctival mucosa and 
upper respiratory tract are connected by the 
nasolacrimal duct, and since they share 
ACE2 on their cell membrane, dental 
healthcare personnel are at risk of infection 
via direct exposure of the conjunctiva to 
droplets from patients during dental 
treatment.15,46 
The limitations of this study include 
not using a larger sample size and neglecting 
the investigation of moderate and severe 
hospitalized cases of the disease, both of 
which could help elucidate the actual 
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association. Furthermore, since this was a 
retrospective study, it was unfeasible to 
control oral hygiene measures during the 
infection stage. 
Based on our findings, it can be 
concluded that gingival bleeding may be 
considered a COVID-19 introductory sign 
and is a prevalent symptom as reported by 
infected patients. However, COVID-19 is a 
non-binary respiratory infection and it is 
well established now that there is a dose 
dependent relation between the viral load 
and signs of the disease. Gingival bleeding 
may be subject to the same dependency. 
During the pandemic, we recommend that 
dentists and periodontists take this 
symptom, as well as any other oral signs that 
may be linked to COVID-19, into 
consideration when screening new patients, 
who may be asymptomatic carriers of the 
disease or in the prodromal phase of 
infection. Additionally, proper universal 
infection control protocols and guidelines 
must be strictly abided by to protect dental 
practitioners worldwide. 
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